i
Comparison of Estimated SARS-CoV-2 Seroprevalence through Commercial Laboratory Residual Sera Testing and a Community Survey
-
December 10 2020
-
-
Source: Clin Infect Dis. 2020;
Details:
-
Alternative Title:Clin Infect Dis
-
Personal Author:
-
Description:We compared severe acute respiratory syndrome-related coronavirus-2 seroprevalence estimated from commercial laboratory residual sera and a community household survey in metropolitan Atlanta during April-May 2020 and found these two estimates to be similar (4.94% versus 3.18%). Compared with more representative surveys, commercial sera can provide an approximate measure of seroprevalence.
-
Subjects:
-
Source:
-
Pubmed ID:33300579
-
Pubmed Central ID:PMC7799302
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: